These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8918742)

  • 1. Protection and defence mechanisms in HCV infection.
    Inchauspé G
    Nephrol Dial Transplant; 1996; 11 Suppl 4():6-8. PubMed ID: 8918742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.
    Rosen HR
    Liver Transpl; 2003 Nov; 9(11):S35-43. PubMed ID: 14586893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of neutralizing antibodies and cellular immunity in hepatitis C virus infection].
    Inchauspé G
    Transfus Clin Biol; 2001 Dec; 8(6):471-4. PubMed ID: 11802609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of hepatitis C vaccines.
    Garcia A; Fernandez S; Toro F; De Sanctis JB
    Recent Pat Inflamm Allergy Drug Discov; 2014; 8(2):85-91. PubMed ID: 25000932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine.
    Thimme R; Neumann-Haefelin C; Boettler T; Blum HE
    Biol Chem; 2008 May; 389(5):457-67. PubMed ID: 18953713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of T cell immunity in hepatitis C virus infections.
    Claassen MA; Janssen HL; Boonstra A
    Curr Opin Virol; 2013 Aug; 3(4):461-7. PubMed ID: 23735335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
    Elmowalid GA; Qiao M; Jeong SH; Borg BB; Baumert TF; Sapp RK; Hu Z; Murthy K; Liang TJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8427-32. PubMed ID: 17485666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive immune responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Curr Top Microbiol Immunol; 2013; 369():243-62. PubMed ID: 23463204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection.
    Puig M; Major ME; Mihalik K; Feinstone SM
    Vaccine; 2004 Feb; 22(8):991-1000. PubMed ID: 15161076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
    Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
    J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.
    Lee H; Jeong M; Oh J; Cho Y; Shen X; Stone J; Yan J; Rothkopf Z; Khan AS; Cho BM; Park YK; Weiner DB; Son WC; Maslow JN
    Sci Rep; 2017 Mar; 7():43531. PubMed ID: 28266565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.